STOCK TITAN

Ekso Bionics to Present at the H.C. Wainwright Global Investment Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Ekso Bionics Holdings, listed under the symbol EKSO, will present at the H.C. Wainwright Global Investment Conference from May 23-26, 2022. The pre-recorded presentation will be available on-demand starting at 4:00 AM PT / 7:00 AM ET on May 24, 2022, and can be accessed on the investor section of the company's website.

As a leader in exoskeleton technology, Ekso Bionics focuses on enhancing human strength and mobility for both medical and industrial applications. Established in 2005, the company is headquartered in the San Francisco Bay Area.

Positive
  • None.
Negative
  • None.

RICHMOND, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO), an industry leader in exoskeleton technology for medical and industrial use, today announced that management will present at the H.C. Wainwright Global Investment Conference taking place May 23-26, 2022.

The pre-recorded presentation will be available to view on-demand as of 4:00 AM PT / 7:00 AM ET, Tuesday, May 24, 2022 throughout the entirety of the conference and on the investor section of the Company’s website at www.eksobionics.com.

About Ekso Bionics® 
Ekso Bionics® is a leading developer of exoskeleton solutions that amplify human potential by supporting or enhancing strength, endurance, and mobility across medical and industrial applications. Founded in 2005, the Company continues to build upon its industry-leading expertise to design some of the most cutting-edge, innovative wearable robots available on the market. Ekso Bionics is the only exoskeleton company to offer technologies that range from helping those with paralysis to stand up and walk, to enhancing human capabilities on job sites across the globe. Ekso Bionics is headquartered in the San Francisco Bay Area and is listed on the Nasdaq Capital Market under the symbol “EKSO.” For more information, visit: www.eksobionics.com or follow @EksoBionics on Twitter.

Investor Contact:
David Carey
212-867-1768
investors@eksobionics.com 

 


FAQ

When will Ekso Bionics present at the H.C. Wainwright Global Investment Conference?

Ekso Bionics will present at the H.C. Wainwright Global Investment Conference from May 23-26, 2022.

How can I view Ekso Bionics' presentation at the conference?

The pre-recorded presentation will be available on-demand starting at 4:00 AM PT / 7:00 AM ET on May 24, 2022, on their website.

What is the focus of Ekso Bionics' technology?

Ekso Bionics specializes in exoskeleton technology that enhances strength, endurance, and mobility for medical and industrial use.

What is the stock symbol for Ekso Bionics?

The stock symbol for Ekso Bionics is EKSO.

Where is Ekso Bionics headquartered?

Ekso Bionics is headquartered in the San Francisco Bay Area.

Ekso Bionics Holdings, Inc.

NASDAQ:EKSO

EKSO Rankings

EKSO Latest News

EKSO Stock Data

13.42M
20.03M
7.91%
25.25%
0.39%
Medical Instruments & Supplies
General Industrial Machinery & Equipment, Nec
Link
United States of America
SAN RAFAEL